Founded in 2019, the firm is focused on developing products for the diagnosis and therapy of blood cancers and other indications not addressed by nuclear medicine. 

TPG will not own a majority of the e-prescriber, with CVS Health and Express Scripts maintaining a minority stake.

Two weeks ago, the FTC launched a similar antitrust suit. The pharmacy benefit managers and pharmaceutical companies are accused of artificially raising drug costs through rebates and kickbacks.

Some of Medtronic's 600 and 700 series MiniMed insulin pumps are experiencing significant battery issues when dropped, bumped or impacted in any way. This has been linked to reports of health issues in more than 180 patients.

Several such IR procedures require US guidance, but a new study is questioning the modality’s effectiveness in reducing complication rates. 

Prosecutors said Ester Mbaya stole Medicare funds and took out lines of credit using falsified documents. She pleaded guilty to the charges.

Three factors are associated with true high-risk findings—imaging protocols for aortic valve implantation planning, imaging area, and cardiology department orders.

Millions of heart failure patients who qualify for standard medical therapies do not receive treatment due to poor health literacy, limited access to care and medication costs.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Deep fakes are more dangerous to healthcare than we may have thought.